Projects per year
Personal profile
Research interests
Research is concentrated in the areas of chemical biology, enzymology, enzyme kinetics, Drug Discovery and Cancer Research. Chemical Biology techniques are used to investigate enzymes as therapeutic targets, and the development of inhibitors as drugs to treat diseases where there is unmet need.
Current research (with Dr Tim Woodman and Professor Mike Threadgill from the Department of Pharmacy & Pharmacology, Professor Tony James from the department of Chemistry, and Professor Ravi Acharya from the Department of Biology & Biochemistry) is focussed on the enzyme alpha-methylacyl-CoA racemase (AMACR), which drives prostate cancer aggressiveness and the aggressiveness of several other cancers. AMACR is also a potential druig target in tuberculosis. AMACR is involved in the degradation of dietary and other branched-chain fatty acids and the activation of ibuprofen. Studies on AMACR have including investigations of the enzyme reaction mechanism using labelling studies and other techniques, development of activity assays, and drug development using rational design and high-throughput screening approaches. We are also interested in development of AMACR assays for use as clinical diagnostic tests.
Other projects include targeting enzymes that use NAD+ as an electrophile (such as tankyrases) with rationally designed drugs (led by Professor Mike Threadgill) and novel systems for delivery of super-potent drugs (led by Professor Threadgill, with Dr Andy Thompson). Each of these projects uses Chemical Biology as part of a multi-disciplinary approach and is focussed on the treatment of cancer.
Areas of expertise: Cancer Research using Chemical Biology approaches; Drug Discovery; Enzyme assays; Enzyme Inhibitors; Enzyme Kinetics; High-Throughput Screening; Ibuprofen and related drugs.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Doctor of Philosophy, University of Oxford
Sep 1989 → Dec 1992
Award Date: 1 Dec 1992
Bachelor of Science, University of Leicester
Oct 1986 → Jun 1989
Award Date: 1 Jun 1989
External positions
Fellow of the Royal Society of Biology (FRSB), Royal Society of Biology
Jan 2018 → 31 Dec 2021
Editorial Board Member for The Biochemist, Biochemical Society
Sep 2017 → …
Member, Biochemical Society
Jan 1990 → …
Keywords
- QD Chemistry
- chemical biology
- prostate cancer
- tuberculosis
- Enzymes
- Enzyme mechanism
- enzyme assays
- enzyme kinetics
- enzyme inhibitors
Fingerprint
- 1 Similar Profiles
Network
-
-
Advanced Inhibitors of Tankyrases 1 and 2, Critical Pathways in Cancer
Threadgill, M., Lloyd, M. & Tosh, D.
1/10/15 → 30/09/16
Project: UK charity
-
AMACR Targeted Drugs for Treating Advance Prostate Cancer
Lloyd, M., James, T., Jevglevskis, M., Nathubhai, A., Threadgill, M. & Woodman, T.
1/02/15 → 30/07/18
Project: UK charity
-
Advanced Inhibitors of Tankyrases 1 and 2, Critical Pathways in Cancer
Threadgill, M., Lloyd, M., Tosh, D. & Nathubhai, A.
1/10/14 → 30/09/15
Project: UK charity
-
Refinement of a Polymeric System Delivering CGIs to Prostate Tumours
Threadgill, M., Lloyd, M. & Thompson, A.
1/10/14 → 30/09/17
Project: UK charity
-
Racemases and epimerases operating through a 1,1-proton transfer mechanism: Reactivity, mechanism and inhibition
Lloyd, M., Jevglevskis, M., Nathubhai, A., James, T., Threadgill, M. & Woodman, T., 24 May 2021, In: Chemical Society Reviews. 50, 10, p. 5952–5984 33 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (SciVal) -
Selenium status in diet affects acetaminophen-induced hepatotoxicity via interruption of redox environment
Li, J., Cheng, P., Li, S., Zhao, P., Han, B., Ren, X., Zhong, J. L., Lloyd, M. D., Pourzand, C., Holmgren, A. & Lu, J., 10 Jun 2021, In: Antioxidants & Redox Signaling. 34, 17, p. 1355-1368 14 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Citations (SciVal)6 Downloads (Pure) -
Steady-State Enzyme Kinetics
Lloyd, M., 30 Jun 2021, The Biochemist, 43, 3, p. 40-45 6 p.Research output: Contribution to specialist publication › Article
Open AccessFile27 Downloads (Pure) -
UVA-Triggered Drug Release and Photo-Protection of Skin
Karisma, V. W., Wu, W., Lei, M., Liu, H., Nisar, M. F., Lloyd, M., Pourzand, C. & Li Zhong, J., 11 Feb 2021, In: Frontiers in Cell and Developmental Biology. 9, 598717.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (SciVal) -
Why some screening hits are a PAIN
Lloyd, M., 7 Jun 2021, Drug Target Review, 8, 2, p. 42-44 3 p.Research output: Contribution to specialist publication › Article
Open Access